Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-responders is a research paper published in Frontiers in Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDCR NIH HHS
Grant: R01 DE028420
NIDCR NIH HHS
Grant: R01 DE031947
NIDCR NIH HHS
Grant: R01 DE027329
NCI NIH HHS
Grant: T32 CA174648
NIDCR NIH HHS
Grant: F31 DE027854
National Institutes of Health
Grant: 5R01DE027329-02
Elucidating Mechanism of Immune Evasion in Head and Neck Cancers
National Institutes of Health
Grant: 5R01DE028420-02
Mechanisms of dual inhibition of TGFbeta/PD-L1 in HNSCC
National Institutes of Health
Grant: 3T32CA174648-02S1
Training in Translational Research of Lung, Head and Neck Cancer
National Institutes of Health
Grant: 5R01DE031947-02
Identifying cellular and molecular signatures from distinct T cell receptor clonotypes associated with favorable immune checkpoint inhibitor responses in HNSCCs
National Institutes of Health
Grant: 1F31DE027854-01
Mechanisms underlying therapy failure of immune checkpoint inhibitors and Notch1 loss-mediated immunosuppression in head and neck cancers
FWCI
0.12
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals